Role of Panchakarma therapy in management of hip bone damage due to Avascular Necrosis

An Open label Clinical Trial to Evaluate the Efficacy of PK AVN1 in the Management of Avascular Necrosis of Femoral Head - nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/07/114102

Enrollment

Registered

2026-07-15

Start date

Unknown

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M955- Acquired deformity of pelvis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with grade II and grade III Avascular Necrosis of Femoral Head 2. Patient having signs and symptoms of Avascular Necrosis of Femoral Head 3. Patients fit for Basti & Patrapinda Sweda 4. Patients fit for Virechana 5. Patients fit for Jalaukavcharana 6. Age- 18-60 years

Exclusion criteria

Exclusion criteria: Patients known case of sickle cell anemia, Thalassemia, Uncontrolled Hypertension, Septic Arthritis and any active and serious systemic diseases.

Design outcomes

Primary

Measure	Time frame
1. Changes in MRI 2. Changes in Harris Hip Score Timepoint: 1. MRI (at basline day & after follow up) 2. Harris Hip Score (at 0th, after 1st cycle, after 2nd cycle, after 3rd cycle, follow up)	—

Secondary

Measure	Time frame
1. Probable risk factors 2. Observe effect on BMI 3. Change in Quality of life (SF-12) Timepoint: baseline day and follow up	—

Countries

India

Contacts

Public ContactDr Gopesh Mangal

National Institute of Ayurveda

gopesh.pk@nia.edu.in8619849011

Outcome results